GLPG: Galapagos Company Aggregate Debts

Symbol and logo of brand Galapagos N.V. (GLPG)

Galapagos NV attracts top pharmacologists through the synergy of academic freedom and substantial capital. The firm has prioritized the implementation of ESG standards to minimize waste and ensure ethical testing. This daily price action on the GURU.Markets chart, via the debt mass indicator, confirms financial stability, where the 0.00 level reflects the current state. The strategy now relies on the active acquisition of promising biotech startups to diversify assets.

GLPG: Galapagos NV Company Debts 07/04/2022 - 05/08/2026

Galapagos (GLPG) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
Price Performance Chart Galapagos Corp|GLPG - Analyst Consensus Forecast
- market capitalization information:
Market Capitalization Galapagos Genomics|GLPG - Total Company Value
- balance sheet equity data:
Accounting Value of a Share Galapagos|GLPG - Company Book Value|Market Cap to Net Assets Ratio glpg.com|GLPG - Company Total Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital Galapagos NV|GLPG - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Galapagos N.V.|GLPG - Company Debts|Debts to Book Value Galapagos Genomics|GLPG - Company Long-Term Liabilities|Amount of Current Liabilities Galapagos|Intermediate Coverage Ratio glpg.com
- earnings and valuation multiples information:
GLPG - Net Profit
Fundamental company analysis:GLPG - Galapagos Corp
Signature product of Galapagos N.V.

Galapagos NV (GLPG) is aggressively scaling decentralized CAR-T therapy production through startup acquisitions, a strategy requiring significant capital expenditures. The total borrowing size reflects the ratio of total debt to current market capitalization, allowing for an assessment of credit leverage and the business's financial stability; an increase in this ratio signals risk, while its decline confirms the fundamental stability of the share price.

Who Galapagos NV competes with

HLN (Haleon Corp) - Aggregate Debt Obligations|Company Aggregate Debts KVUE (Kenvue Inc.)|Company Aggregate Debts veronapharma.com VRNA|MENS - Company Debts|Aggregate Debt Obligations LGND (Ligand Pharmaceuticals Incorporated)|Amneal Pharmaceuticals Inc (AMRX) - Company Debts|Company Total Debt Perrigo Corp|ALVO (Alvotech) - Company Aggregate Debts|Company Aggregate Debts liquidia.com|Company Total Debt ANIP (ANI Pharmaceuticals, Inc.)|MNKD (MannKind Corp) - Aggregate Debt Obligations|Company Debts Amphastar AMPH|Pacira Corp (PCRX) - Company Cumulative Debt|SPRY: Company Total Debt|theravance.com - Company Cumulative Indebtedness|AQST: Company Aggregate Debts|scPharmaceuticals - Aggregate Debt Obligations|TECX (Tectonic Therapeutic Inc.) - Company Aggregate Debts|Company Cumulative Debt Tonix Pharmaceuticals Holding TNXP|Company Debts China SXT Pharmaceuticals (SXTC)|EPRX (eupraxiapharma.com) - Aggregate Debt Obligations|Company Aggregate Debts BHST (BioHarvest Sciences Inc.)|Company Total Indebtedness Invizyne Technologies|Oramed Pharma - Company Aggregate Debts|ENTX - Company Aggregate Debts|MindWalk Holdings (HYFT) - Company Debts|ABVC (abvcpharma.com) - Company Debts|CPIX (Cumberland Pharmaceuticals Inc.) - Company Aggregate Debts|Company Aggregate Debts Quantum BioPharma Ltd.|Company Debts FibroGen Corp (FGEN)|TELO: Company Aggregate Indebtedness|Company Aggregate Debts RANI (Rani Therapeutics Holdings, Inc.)|Company Aggregate Debts Synergy CHC Corp. SNYR|Rallybio Corp. - Company Aggregate Debts|Company Total Indebtedness Lexaria Bioscience (LEXX)|Pulmatrix Corp (PULM) - Company Debts|Company Cumulative Debt Pheton Holdings (PTHL)|Company Debts Aptorum Group Ltd|lyratherapeutics.com (LYRA) - Company Total Debt Obligations|Company Total Debt IBO (Impact BioMedical)|TNFA (tnfpharma.com) - Aggregate Debt Obligations|Company Debts cbdMD YCBD|PRFX: Company Aggregate Debt|CYTO: Company Total Debt|LIPO: Company Debts|OPTN: Company Aggregate Debts|Company Total Indebtedness Pieris Pharmaceuticals Inc PIRS|Company Debts Procaps Group SA|Company Debts PTPI|Company Debts Qilian International (QLI)|SLRN: Company Aggregate Indebtedness|Company Aggregate Debts TFFP (TFF Pharmaceuticals, Inc.)